Risk factors for vascular invasion of primary liver cancer

Chang XiuJuan; Lu YinYing; Rong GuangHua; Liu Ze; Chen Yan; Xu GuiLin; Gao XuDong; Lou Min; Wang ChunPing; Yang YongPing; Ceng Zhen

doi:10.3969/j.issn.1001-5256.2018.05.022

Issue 5

May 2018

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2018 > 34(5): 1038-1041

PDF( 251 KB)

Risk factors for vascular invasion of primary liver cancer

DOI: 10.3969/j.issn.1001-5256.2018.05.022

Liver Cancer Treatment and Research Center, 302 Hospital of PLA

Research funding:

Received Date: 2017-11-16
Published Date: 2018-05-20

Abstract

Abstract

Objective To investigate the risk factors for vascular invasion of primary liver cancer ( PLC) . Methods A retrospective analysis was performed for the clinical data of 211 patients with liver cancer who were hospitalized in 302 Hospital of PLA from January 2013 to June 2014. The logistic regression model fitting was used for the data of 133 patients, and the data of the other 78 patients was used for the verification of this model. Univariate and multivariate logistic regression analyses were used to identify the influencing factors for vascular invasion of PLC; the logistic regression model was established and the receiver operating characteristic ( ROC) curve was plotted to determine the optimal cut-off value of this model. Results The univariate logistic regression analysis showed that tumor diameter ( odds ratio [OR]= 1. 594, 95% confidence interval [CI]: 1. 376-1. 846, P = 0) , neutrophil-lymphocyte ratio ( NLR) ( OR = 2. 783, 95% CI: 1. 847-4. 195, P = 0) , platelet-to-lymphocyte ratio ( PLR) ( OR = 1. 016, 95% CI: 1. 008-1. 024, P = 0) , fibrinogen ( Fb) ( OR = 2. 295, 95% CI: 1. 608-3. 274, P = 0) , and lymph node metastasis ( OR = 11. 664, 95% CI: 3. 744-36. 338, P = 0) were risk factors for vascular invasion of PLC; the multivariate logistic regression analysis showed that tumor diameter ( OR = 1. 506, 95% CI: 1. 250-1. 815, P =0) , PLR ( OR = 1. 499, 95% CI: 0. 173-0. 998, P = 0. 022) , NLR ( OR = 2. 491, 95% CI: 1. 411-4. 397, P = 0. 002) , and Fb ( OR = 1. 486, 95% CI: 1. 008-2. 193, P = 0. 046) were used for regression model fitting. The area under the ROC curve was 0. 927 ( 95% CI: 0. 881-0. 973) , and the ROC curve showed that the model had the highest sensitivity of 92. 9%, the highest specificity of86. 5%, and a prediction accuracy rate of 82. 79%. Conclusion The regression equation containing tumor diameter, PLR, NLR, and Fb established in this study has a high prediction accuracy of vascular invasion of PLC and provides a reference for early warning of vascular invasion of PLC.
- liver neoplasms,
- vascular invasion,
- risk factors,
- logistic models

FullText(HTML)

References(16)

References

[1] SIEGEL RL, MILLER KD, JEMAL A.Cancer Statistics, 2017[J].CA Cancer J Clin, 2017, 67 (1) :7-30.

[2]PEREA del POZO E, BERNAL BELLIDO C, SENDIN MATIN M, et al.Recurrent hepatocellular carcinoma after liver transplantation:analysis of risk factors[J].2016, 48 (9) :2990-2993.

[3]LI QL, WEN XX, LI KZ, et al.A study on the anti-tumor mechanism of total flavonoids from radix tetrastigmae against additional cell line based on COX-2-mediated Wnt/β-catenin signaling pathway[J].Oncotarget, 2017, 8 (33) :54304-54319.

[4]LLOVET JM, BRU C, BRUIX J.Prognosis of hepatocellular carcinoma:the BCLC staging classification[J].Semin Liver Dis, 1999, 19 (3) :329-338.

[5]HSUEH C, TAO L, ZHANG M, et al.The prognostic value of preoperative neutrophils, platelets, lymphocytes, monocytes and calculated ratios in patients with laryngeal squamous cell cancer[J].Oncotarget, 2017, 8 (36) :60514-60527.

[6]INAOKA K, KANDA M, UDA H, et al.Clinical utility of the platelet-lymphocyte ratio as a predictor of postoperative complications after radical gastrectomy for clinical T2-4 gastric cancer[J].World J Gastroenterol, 2017, 23 (14) :2519-2526.

[7]LUO G, LIU C, CHENG H, et al.Neutrophil-lymphocyte ratio predicts survival in pancreatic neuroendocrine tumors[J].Oncol Lett, 2017, 13 (4) :2454-2458.

[8]PANG Z, DING N, DONG W, et al.Prognostic effects of preoperative obstructive pneumonitis or atelectasis and comparison with tumor size in non-small cell lung cancer[J].J Thorac Dis, 2017, 9 (3) :768-778.

[9]PEDRAZZANI C, MANTOVANI G, FERNANDES E, et al.Assessment of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and platelet count as predictors of long-term outcome after R0 resection for colorectal cancer[J].Sci Rep, 2017, 7 (1) :1494.

[10]KYRIAZI V, THEODOULOU E.Assessing the risk and prognosis of thrombotic complications in cancer patients[J].Arch Pathol Lab Med, 2013, 137 (9) :1286-1295.

[11]del PRINCIPE MI, BUCCISANO F, MAURILLO L, et al.Infections increase the risk of central venous catheter-related thrombosis in adult acute myeloid leukemia[J].Thromb Res, 2013, 132 (5) :511-514.

[12]FU SJ, SHEN SL, LI SQ, et al.Prognostic value of preoperative peripheral neutrophil-to-lymphocyte ratio in patients with HBVassociated hepatocellular carcinoma after radical hepatectomy[J].Med Oncol, 2013, 30 (4) :721.

[13]CHEN L, LI Q, ZHOU XD, et al.Increased pro-angiogenic factors, infiltrating neutrophils and CD163 (+) macrophages in bronchoalveolar lavage fluid from lung cancer patients[J].Int Immunopharmacol, 2014, 20 (1) :74-80.

[14]ZHAO NN, YANG YT, ZHOU F, et al.The relationship between the function of blood coagulation and clinical classification in patients with hepatitis B[J].Lab Med Clin, 2017, 14 (3) :314-316. (in Chinese) 赵妮娜, 杨玉婷, 周芬, 等.慢性乙型肝炎患者病程转归与凝血功能相关指标分析[J].检验医学与临床, 2017, 14 (3) :314-316.

[15]HUANG J, YANG ZJ, ZHANG JQ, et al.Analysis about the high risk factors and prognosis of gynecologic cancer with deep venous thrombosis[J].Chin J Obstetr Gynecol, 2015, 50 (10) :762-769. (in Chinese) 黄静, 阳志军, 张洁清, 等.妇科恶性肿瘤并发深静脉血栓形成的危险因素及预后影响因素分析[J].中华妇产科杂志, 2015, 50 (10) :762-769.

[16]DING M, ZHANG QY, JING Y, et al.Role of inflammatory and coagulation factors in acute deep venous thrombosis and the correlation[J].Chin J Med Offic, 2016, 44 (1) :1175-1177. (in Chinese) 丁萌, 张青云, 景阳, 等.炎性反应因子及凝血因子在下肢深静脉血栓形成中作用和相关性分析, 2016, 44 (11) :1175-1177.

Relative Articles

[1]	Decai KONG, Xiaojing ZHANG, Yangguang YUN, Haoyu DUAN, Junfeng YE. Risk factors for biliary stricture and prognosis after orthotopic liver transplantation[J]. Journal of Clinical Hepatology, 2024, 40(11): 2253-2259. doi: 10.12449/JCH241119
[2]	Bingbing ZHU, Jinxiang YANG, Qun ZHANG, Fangyuan GAO, Xianbo WANG. Risk factors for the 90-day prognosis of patients with type I hepatorenal syndrome and establishment of a predictive model[J]. Journal of Clinical Hepatology, 2022, 38(7): 1561-1565. doi: 10.3969/j.issn.1001-5256.2022.07.019
[3]	Wanshu LIU, Lijun SHEN, Qinghui ZHAI, Shaojie XIN, Shaoli YOU. Risk factors for acute variceal bleeding in acute-on-chronic liver failure and its influence on prognosis[J]. Journal of Clinical Hepatology, 2022, 38(11): 2532-2536. doi: 10.3969/j.issn.1001-5256.2022.11.018
[4]	Siqin LIU, Xiaomei WANG, Xia LI, Luwen LIANG, Ke WANG, Rui WANG. Covert hepatic encephalopathy in liver cirrhosis: Risk factors and prognosis[J]. Journal of Clinical Hepatology, 2022, 38(2): 359-364. doi: 10.3969/j.issn.1001-5256.2022.02.020
[5]	Ping ZHU, Heping ZHAO, Tao HAN, Qing YE, Tinghong LI, Huiling XIANG. Evaluation and influencing factors of the short-term prognosis of severe alcoholic hepatitis with different underlying liver diseases[J]. Journal of Clinical Hepatology, 2021, 37(2): 370-374. doi: 10.3969/j.issn.1001-5256.2021.02.024
[6]	Zhang DaLi, Feng DanNi, Zhang LiJuan, Tang RuJia, He Xi, Zhou Xia, Gao YinJie, Liu ZhenWen, Liu HongLing. Risk factors for recurrence after liver transplantation in patients with hepatocellular carcinoma and their prognosis[J]. Journal of Clinical Hepatology, 2020, 36(9): 1985-1989. doi: 10.3969/j.issn.1001-5256.2020.09.015
[7]	Li Ying, Zhan Jing, Wang ZhongFeng. Prognostic factors for patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2017, 33(3): 497-501. doi: 10.3969/j.issn.1001-5256.2017.03.020
[8]	Wang FengJiao, Liu MingJiang, Wu RuiHong, Niu JunQi. A multivariate logistic regression analysis of short-term prognosis of patients with hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2017, 33(4): 711-714. doi: 10.3969/j.issn.1001-5256.2017.04.022
[9]	Cui YanPing, Li QingFang, Li QingYan, Liu ChunHua, Wang WeiHong, Yuan JianGuo, Wang SiKui. Logistic regression analysis of prognostic risk factors for hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2016, 32(1): 135-138. doi: 10.3969/j.issn.1001-5256.2016.01.026
[10]	Shi XinXing, Zhang YanQiong, Zhu Peng, Yan GuoHua, Zhang ZhangJiang, Wang YuMing. Prognostic risk factors in patients with hepatitis B virus- related acute- on- chronic liver failure[J]. Journal of Clinical Hepatology, 2016, 32(4): 700-705. doi: 10.3969/j.issn.1001-5256.2016.04.018
[11]	Qiao LiNa, Dai GuangRong, Zhang Jin, Shen Ni. An epidemiological survey of prevalence and risk factors for fatty liver disease in adults residing in Yan'an,China[J]. Journal of Clinical Hepatology, 2015, 31(1): 82-87. doi: 10.3969/j.issn.1001-5256.2015.01.018
[12]	Chen YongFang, Wu ZhanJun. Pathogenesis and risk factors of cholesterol gallstones in patients with non- alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2013, 29(12): 952-955. doi: 10.3969/j.issn.1001-5256.2013.12.021
[13]	Wu XiaoQing, Wan Hong. Causes of liver failure and impact analysis of prognostic risk factors[J]. Journal of Clinical Hepatology, 2013, 29(4): 294-296+304.
[14]	Zhang DongQing, Chen Li, Gan QiaoRong, Zhou Rui, Huang JianRong, Pan Chen. Prognostic factors for hepatitis B acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2012, 28(10): 740-743.
[15]	Liu HongHong, Fu JunLiang, Fu BaoYun, Zhang Zheng, Xu RuoNan, Luo ShengQiang, Shi Ming, Li YongGang, Wang FuSheng. The pathogenesis and risk factors related to prognosis of primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2012, 28(2): 153-155.
[16]	Lu: RiYing, Li ShiXiong, Wu JiZhou, Zhu YuJia, Fu ShaoPing. Development of a prognostic factors model for severe hepatitis[J]. Journal of Clinical Hepatology, 2012, 28(10): 789-792.
[17]	Zhang YiNing, Du HongWei, Liu YanJun, Wang ChaoXia. The diagnosis and risk factors for evaluation of nonalcoholic fatty liver disease in children and adolescents[J]. Journal of Clinical Hepatology, 2011, 27(7): 690-693.
[18]	Liu XiaoYan, Li ShengMian, Yang Jian. The incidence and prognosis of non-alcoholic fatty liver disease in primary liver cancer 1293 cases[J]. Journal of Clinical Hepatology, 2010, 26(6): 641-643.
[19]	Chen MingWei, Yang MingGong, Wang YouMin, Wang ZhangJiang, Pan TianRong, Hu HongLin, Sun HaiYan. Risk factors analysis on nonalcoholic steatohepatitis in patients with type 2 diabetes[J]. Journal of Clinical Hepatology, 2004, 20(1): 44-45.
[20]	Ding HuiGuo, Gao GuiJu, Chen Tao, Jin Rui. Prognosis of Severe Types of Virous Hepatitis: Study on Mutiple Risk Factors.[J]. Journal of Clinical Hepatology, 2002, 18(5): 297-299.

Supplements(0)

Cited By

Cited by

Periodical cited type(4)

1.	王静，王佳琪，陈芳，夏杰，李露锋，毛青. ALT正常的慢性乙型肝炎患者抗病毒治疗疗效和安全性的真实世界研究. 重庆医学. 2025(01): 138-141 .
2.	何雄志. 红外肝病治疗仪联合富马酸丙酚替诺福韦治疗慢性乙型肝炎的临床效果. 中外医学研究. 2025(06): 36-39 .
3.	唐海涛，王娴，周佳琦，王凤梅，张文华. 富马酸丙酚替诺福韦治疗初治失代偿期乙型肝炎肝硬化患者的临床研究. 肝脏. 2024(07): 830-833 .
4.	付文鹏，慕少英. 富马酸丙酚替诺福韦治疗慢性乙型病毒性肝炎的临床疗效分析. 系统医学. 2024(23): 39-42 .

Other cited types(2)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (520) PDF downloads(108)

Risk factors for vascular invasion of primary liver cancer

DOI: 10.3969/j.issn.1001-5256.2018.05.022